| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 9 Nov 2024 | 19 Nov 2024 | 20 Nov 2024 | 1 | 10 | Interim |
| Interim Dividend for FY 2024-25 of 10% i.e., Re. 1.00 per equity share of face value of Rs. 10.00 each. The record date for the purpose of payment of Interim Dividend, as intimated earlier will be November 20, 2024 | ||||||
| Dividend | 23 Apr 2024 | 2 May 2024 | 2 May 2024 | 4 | 40 | Interim 2 |
| Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board meeting held on April 23, 2024. Declared 02nd interim dividend of Rs. 04/- (Rupees Four only) per equity share having face alue of Rs. 10/- each for the financial year 2023-24. | ||||||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
